275 related articles for article (PubMed ID: 8394795)
1. Lomefloxacin clinical pharmacokinetics.
Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
[TBL] [Abstract][Full Text] [Related]
2. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Symonds WT; Nix DE
Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
[TBL] [Abstract][Full Text] [Related]
3. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Wijnands GJ; Cornel JH; Martea M; Vree TB
Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
[TBL] [Abstract][Full Text] [Related]
4. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
Nilsen OG; Saltvedt E; Walstad RA; Marstein S
Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068
[TBL] [Abstract][Full Text] [Related]
5. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
Iakovlev VP
Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
[No Abstract] [Full Text] [Related]
6. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
Blum RA
Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
[TBL] [Abstract][Full Text] [Related]
7. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
[TBL] [Abstract][Full Text] [Related]
8. Renal clearance of lomefloxacin is decreased by furosemide.
Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Lebrec D; Gaudin C; Benhamou JP
Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
[TBL] [Abstract][Full Text] [Related]
11. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
12. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days.
Gros I; Carbon C
Antimicrob Agents Chemother; 1990 Jan; 34(1):150-2. PubMed ID: 2327750
[TBL] [Abstract][Full Text] [Related]
14. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Wadworth AN; Goa KL
Drugs; 1991 Dec; 42(6):1018-60. PubMed ID: 1724637
[TBL] [Abstract][Full Text] [Related]
15. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
Staib AH; Harder S; Fuhr U; Wack C
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
[TBL] [Abstract][Full Text] [Related]
16. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
Kolendo SE; Vorob'ev PA; Dvoretskiĭ LI; Izotova GN; Miagkov AV; Shvyreva GS; Iakovlev SV
Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
[TBL] [Abstract][Full Text] [Related]
17. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
Bergogne-Bérézin E; Muller-Serieys C; Kafé H
Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
[TBL] [Abstract][Full Text] [Related]
18. Effect of antacid on absorption of the quinolone lomefloxacin.
Shimada J; Shiba K; Oguma T; Miwa H; Yoshimura Y; Nishikawa T; Okabayashi Y; Kitagawa T; Yamamoto S
Antimicrob Agents Chemother; 1992 Jun; 36(6):1219-24. PubMed ID: 1329615
[TBL] [Abstract][Full Text] [Related]
19. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
Padeĭskaia EN; Iakovlev VP
Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
[No Abstract] [Full Text] [Related]
20. Clinical pharmacokinetics of sparfloxacin.
Shimada J; Nogita T; Ishibashi Y
Clin Pharmacokinet; 1993 Nov; 25(5):358-69. PubMed ID: 8287631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
